Skip to main content
logo
Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
3.825
-0.055 (-1.42%)
At close: Sep 8, 2026, 4:00 PM EDT
3.700
-0.180 (-4.64%)
After-hours: Sep 8, 2026, 4:51 PM EDT

Galmed Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-9.96-8.51-6.28-7.49-17.65-32.88
Net Income
-11.34-10.31-7.52-6.91-17.87-32.47
Earnings Per Share
-14.11-19.13-64.61-239.59-1023.25-1900.66
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.2318.1615.3312.6413.7934.82
Total Debt
0.13--0.040.220.44
Net Cash (Debt)
11.118.1615.3312.613.5734.38
Net Cash Growth
-45.92%18.43%21.66%-7.13%-60.53%-31.88%
Net Cash Per Share
13.8133.69131.76436.79777.152012.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.54-6.32-5.88-6.14-18.5-32.89
Capital Expenditures
-----0-0.01
Free Cash Flow
-8.54-6.32-5.88-6.14-18.51-32.9
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------